Table 3.
UDP diagnosesa
| Frequency | UDP # | Age (y) | Sex | Diagnosis | Basisb | Comment |
|---|---|---|---|---|---|---|
| New diseases | 797 | 54 | F | ACDC | C,P,B, Ms | NT5E mutations |
| 1103 | 51 | M | ACDC | C, Ms | NT5E mutations | |
| 1112 | 49 | F | ACDCc | C,P,B, Ms | NT5E mutations | |
| 1433 | 44 | F | ACDC | C, MS | NT5E mutations | |
| 1889 | 53 | M | ACDC | C, Ms | NT5E mutations | |
| 2457 | 44 | F | ACDC | C,B,P, MT | NT5E mutations | |
| 1706 | 44 | F | Familial distal myopathy | C,P, ME | HINT3 mutation | |
| <60 cases reported | 283 | 48 | F | Leucodystrophy with axonal spheroids | C,P | |
| 338 | 14 | M | Spinocerebellar Ataxia and Hereditary Spastic Paraplegia | C,P,B,ME | Only case of biallelic AFG3L2 mutations | |
| 499 | 7 | F | Pitt-Hopkins syndrome | C,MT | TCF4 mutation | |
| 563 | 3 | M | Hereditary Benign Intraepithelial Dyskeratosis | C,P,Ms | 4q35.2 duplication | |
| 887 | 5 | F | Congenital Disorder of Glycosylation IIb | C,B,MT | Glucosidase I deficiency; sib of 1248 | |
| 1173 | 48 | M | Autosomal Dominant Cerebellar Ataxia | C,P,Ms | LMNB1 duplication | |
| 1248 | 10 | M | Congenital Disorder of Glycosylation lib | C,B,MT | Glucosidase I deficiency | |
| 2226 | 38 | F | Aceruloplasmin-emia | C,B,MT | Cp mutations; neurological involvement | |
| <1/100,000 | 333 | 45 | F | Facial dysautonomia | C | |
| 357 | 36 | M | Hereditary Spastic Paraplegia | C,MT | SPG4 mutations | |
| 608 | 4 | F | Smith-Magenis syndrome | C,MT | RAH mutation | |
| 679 | 31 | F | CSF tetrahydro-biopterin deficiency | C,B | Incidental to devastating cerebral deficits | |
| 752 | 41 | F | Immune-mediated cerebellar degeneration | C,P | Responded to rituximab | |
| 984 | 17 | F | GM1 gangliosidosis | C,B,ME | Normal initial enzyme activity | |
| 997 | 53 | F | Amyloid myopathy | C,B,P | Multiple myeloma | |
| 1074 | 45 | M | Amyotrophic lateral sclerosis | C,MT | SOD1 mutation found | |
| 1262 | 46 | M | Progressive Spastic Paraparesis | C,MT | SPG7 mutations | |
| 1857 | 24 | F | CSF tetrahydro-biopterin deficiency | C,B | Responded to treatment | |
| 1924 | 36 | F | Call-Fleming syndrome | C,P | ||
| 1–10/100,000 | 714 | 40 | M | Primary Progressive Multiple Sclerosis | C,P | |
| 1155 | 29 | M | Neuromyelitis Optica | C | ||
| 2019 | 69 | M | Progressive Supranuclear Palsy & Corticobasal Ganglia Degeneration | C | ||
| 2566 | 57 | M | Corticobasal Ganglionic Degeneration | C | ||
| Common | 368 | 35 | F | Fibromyalgia | C | |
| 800 | 36 | F | Fibromyalgia | C | ||
| 855 | 56 | F | Psychogenic tic cough | C | ||
| 932 | 44 | F | Somatization | C | ||
| 936 | 47 | M | Morgellon's disease | C | ||
| 1137 | 54 | F | Multiple myeloma | C,P | ||
| 1628 | 54 | F | Functional gait disorder | C | ||
| 1868 | 19 | F | Psychogenic movement disorder | C | ||
| 1913 | 36 | M | Fibromyalgia | C |
If a diagnosis was already suggested by the referring center, confirming that diagnosis was not sufficient to claim success.
C, Clinical; P, Pathological; B, Biochemical; Ms, Molecular-SNP; ME, Molecular-Whole Exome; MT, Molecular-Targeted Sequencing
ACDC, Arterial Calcifications due to CD73 Deficiency; cases 1112, 797, 1433, 1103, and 1889 are sibs.
NA, not available.